FindTrial
Sign In

Clinical outcome of risedronate therapy for patients with Paget's disease of bone

Clinical outcome of risedronate therapy for patients with Paget's disease of bone - Clinical outcome of risedronate therapy for patients with Paget's disease of bone

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019338
Enrollment
15
Registered
2015-10-15
Start date
2009-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paget&#39

Interventions

risedronate 17.5mg

Sponsors

Nagoya University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ALP value over normal range

Exclusion criteria

Exclusion criteria: not tolerated for risedronate

Design outcomes

Primary

MeasureTime frame
ALP value—

Countries

Japan

Contacts

Public ContactNishida Yoshihiro

Nagoya University Hospital Orthopaedic Surgery

ynishida@med.nagoya-u.ac.jp052-741-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026